Showing results (171-180 of 201) with videos related to

Sort By:
Pageof 21
European Journal of Cancer (Oxford, England : 1990)|February 1, 2017
Intracerebral injection of CpG oligonucleotide for patients with de novo glioblastoma-A phase II multicentric, randomised studyRenata Ursu, Alexandre Carpentier, Philippe Metellus, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|July 27, 2000
[Opsoclonus-myoclonus syndrome associated with non-metastatic neuroblastoma. Long-term survival. Study of the French Society of Pediatric Oncologists]D Plantaz, J Michon, D Valteau-Couanet, et al.
The New England Journal of Medicine|February 21, 2014
Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastomaOlivier L Chinot, Wolfgang Wick, Warren Mason, et al.
Neuro-Oncology|January 31, 2006
Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastomaAlexandre Carpentier, Florence Laigle-Donadey, Sarah Zohar, et al.
Neuro-Oncology|March 24, 2010
Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II studyAlexandre Carpentier, Philippe Metellus, Renata Ursu, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 20, 2000
Effects of hyperprolactinemia on rat prostate growth: evidence of androgeno-dependenceF Van Coppenolle, C Slomianny, F Carpentier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastomaWolfgang Wick, Vinay K Puduvalli, Marc C Chamberlain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2004
Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletionsK Hoang-Xuan, L Capelle, M Kujas, et al.
Pageof 21